Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Apoptosis in Health and Disease - Part B -

Apoptosis in Health and Disease - Part B

Rossen Donev (Herausgeber)

Buch | Hardcover
356 Seiten
2021
Academic Press Inc (Verlag)
978-0-323-85317-0 (ISBN)
CHF 229,95 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Apoptosis in Health and Disease - Part B, Volume 126 in the Advances in Protein Chemistry and Structural Biology focuses on apoptotic responses in numerous conditions - from bacterial and parasite infections, to pathological states such as oxidative stress, pulmonary hypertension, and different cancer types, etc. In addition, the book provides therapeutic strategies for targeting apoptosis. These new advanced understandings are playing a major influence in drug discovery and the introduction of new therapies that target the cell death process.

Apoptosis, or programmed cell death, is the mechanism by which cells die either physiologically or pathologically. Vast research in apoptosis has advanced our understanding of basic physiological and pathological processes occurring in cells, organs and organisms, and its role in a number of diseases.

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

Contributors in the volume include:
Santi Prasad Sinha Babu
Soundarapandian KANNAN
Soundarapandian KANNAN
Dayanidhi Raman
Gautam Sethi
Mohammad Abid
Pankaj Taneja
Anupam Bishayee
Harikumar KB
Natella Enukashvily
Sadhana R. Joshi
Ali Akbar Moosavi-Movahedi

Erscheinungsdatum
Reihe/Serie Advances in Protein Chemistry and Structural Biology
Verlagsort Oxford
Sprache englisch
Maße 152 x 229 mm
Gewicht 680 g
Themenwelt Naturwissenschaften Biologie Biochemie
Naturwissenschaften Biologie Genetik / Molekularbiologie
Naturwissenschaften Biologie Zellbiologie
ISBN-10 0-323-85317-X / 032385317X
ISBN-13 978-0-323-85317-0 / 9780323853170
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Reinhard Matissek; Andreas Hahn

Buch | Hardcover (2024)
Springer Spektrum (Verlag)
CHF 109,95

von Birgit Piechulla; Hans Walter Heldt

Buch | Hardcover (2023)
Springer Spektrum (Verlag)
CHF 109,95